Furthermore, because we did not demonstrate that PR1-CTL were directly cytotoxic against CML cells or against LSC in particular, it is possible that the observed changes in the number of PR1-CTL may merely reflect changes in the leukemia burden. The gene discussed is TMEM37; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.